若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系。

CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention

CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention

腾讯云视频点播

阿里云视频点播

https://outin-9a16319b20f811f1844a00163e32a995.oss-cn-shanghai.aliyuncs.com/sv/29e0c28f-19cf5ed0b29/29e0c28f-19cf5ed0b29.mp4?Expires=1773905679&OSSAccessKeyId=LTAI8bKSZ6dKjf44&Signature=wxq6XSCCexOdqV3o9LVd%2BvPaFP4%3D
In this webinar, Dr. Egelston discusses recent efforts to isolate and characterize phenotypically and functionally exhausted CD8+ TILs from a subset of breast tumors.
发布日期: 08/30/2019
Copyright © 2026 by STEMCELL Technologies. All rights reserved.

在线联系